EMLA Cream is a topical anesthetic used to numb the skin before certain medical procedures. It contains two active substances, lidocaine and prilocaine, which belong to a group of medicines called local anesthetics. The cream works by numbing the surface of the skin for a short time, helping to stop pain on the skin, although the patient may still have the feelings of pressure and touch.
Product Details:
- Each gram of EMLA Cream contains 25 mg of lidocaine and 25 mg of prilocaine.
- The cream is a white soft cream.
- The Marketing Authorisation for EMLA Cream 5% is held by Aspen.
- EMLA Cream 5g packs with dressings are manufactured by Aspen, while EMLA Cream 5g packs without dressings are manufactured by Or.
- The medicinal product is authorized in various Member States of the EEA under different names, such as Emla 5% in Austria, Emla 25mg/25mg crème in Belgium, and Emla Cream 5% in Cyprus.
Positive Effects:
- EMLA Cream facilitates the needle procedure compared to placebo cream, regardless of the vascular response.
- EMLA reduces the number of cleansing sessions required to achieve a clean ulcer compared to debridement with placebo cream, with no negative effects on ulcer healing.
Negative Effects:
- The adverse drug reactions for EMLA (lidocaine and prilocaine) include data from both clinical and post-marketing experience, but specific details are not provided in the search results.
Ingredients:
- Active Ingredients: Lidocaine 2.5% w/w (25 mg/g) and Prilocaine 2.5% w/w (25 mg/g).
- Excipients: Macrogolglycerol hydroxystearate, Carbomer 974P, sodium hydroxide, and purified water.
- Nonmedicinal Ingredients: Carboxypolymethylene, polyoxyethylene, hydrogenated castor oil, and sodium hydroxide to adjust pH to 8.7-9.7.
